In the biopharma industry, the greatest achievements occur when inspiring science is paired with enabling technology. To better contribute to such achievements, two providers of innovative tools and ...
Significant Cost Synergies to Increase Profitability and Accelerate Breakeven Horizon in 2024, Earlier Than Berkeley Lights Expected as a Standalone Entity Sean Mackay, co-founder and chief executive ...
News Medical on MSN
Bruker advances Functional Proteomics 2.0 with timsOmni™ mass spectrometry proteoform analysis for deeper insights into disease biology
Bruker Corporation today announced new advancements to enable Functional Proteomics 2.0 workflows on the timsOmni ™ mass spectrometer to enable disease researchers to move beyond canonical protein ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results